SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP
14 references·8 citing·42 second hop
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP (1993)A comparison of the behavioral effects of…Obsessive Compulsive Disorder (2022)Obsessive Compulsive DisorderDiagnostic and Statistical Manual of Mental Disorders (2013)Diagnostic and Statistical Ma…Serotonergic Function in Obsessive-Compulsive Disorder (1992)Serotonergic Function in Obse…Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder (1991)Metergoline blocks the behavi…Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder (1991)Effects of chronic fluoxetine…Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder (1990)Controlled Comparisons of Clo…Clomipramine in Obsessive-Compulsive Disorder (1989)Clomipramine in Obsessive-Com…Serotonin Function in Obsessive-Compulsive Disorder (1988)Serotonin Function in Obsessi…Serotonergic Responsivity in Obsessive-Compulsive Disorder (1988)Serotonergic Responsivity in …Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings (1988)Serotonergic and noradrenergi…Serotonergic Responsivity in Obsessive-Compulsive Disorder (1987)Serotonergic Responsivity in …The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam (1985)The Influence of Ritanserin, …Obsessive-Compulsive Disorder (1983)Obsessive-Compulsive DisorderClomipramine Treatment of Obsessive-Compulsive Disorder (1980)Clomipramine Treatment of Obs…Current animal models of obsessive compulsive disorder: an update (2011)Current animal models of obse…Serotonergic Dissection of Obsessive Compulsive Symptoms: A Challenge Study with m-Chlorophenylpiperazine and Sumatriptan (2004)Serotonergic Dissection of Ob…5-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders (2002)5-HT2A promoter polymorphism …Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder (2001)Sumatriptan, 5-HT1D receptors…Neurobiology and Clinical Pharmacology of Obsessive-Compulsive Disorder (2001)Neurobiology and Clinical Pha…Obsessive Compulsive Disorder: Serotonin and Beyond (2000)Obsessive Compulsive Disorder…Single photon emission computed tomography op the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor (1999)Single photon emission comput…m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation (1995)m-Chlorophenylpiperazine in p…A RATING SCALE FOR DEPRESSION (1960)5-HIAA in the Cerebrospinal Fluid (1976)Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites (1984)Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder (1994)Obsessive-Compulsive Disorder (2014)The Yale-Brown Obsessive Compulsive Scale (1989)The Yale-Brown Obsessive Compulsive Scale (1989)Compulsive Sexual Behavior (1991)Practice Parameters for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder (1998)Evidence-based pharmacotherapy of obsessive–compulsive disorder (2005)Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1 (1980)Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder (1985)Altered Serotonin Activity in Anorexia Nervosa After Long-term Weight Restoration (1991)A meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy (1994)A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE (1978)Research Diagnostic Criteria (1978)A New Depression Scale Designed to be Sensitive to Change (1979)Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review. (1997)A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Åsberg Depression Rating Scale (MADRS) (2001)Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology (1987)[18F]FDG PET Study in Obsessive–Compulsive Disorder (1995)Obsessive-compulsive disorder (2002)Pathophysiology of obsessive–compulsive disorder (2004)Development of a Rating Scale for Primary Depressive Illness (1967)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)Obsessive-compulsive disorder and serotonin: Is there a connection? (1985)Clomipramine Hydrochloride in Childhood and Adolescent Obsessive-Compulsive Disorder—a Multicenter Trial (1992)Demographic and Clinical Features of Obsessive-Compulsive Disorder in Children and Adolescents (1995)Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder (1988)Obsessive-Compulsive Disorder in Children and Adolescents (1989)Anxiety Disorders of Childhood and Adolescence: A Critical Review (1991)Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder (2004)Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2008)Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder (1988)Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin (1990)Neurobiology of panic disorder: From animal models to brain neuroimaging (2008)Obsessive-Compulsive Spectrum Disorders: An Overview (1993)Toward a unified theory of serotonin dysregulation in eating and related disorders (1995)Multiple pathways to functional impairment in obsessive–compulsive disorder (2009)The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories (1995)Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. (2003)The benefits of being present: Mindfulness and its role in psychological well-being. (2003)
this work references cited by second hop

References

  • 2013Diagnostic and Statistical Manual of Mental Disorders109,522 cited
  • 1980Clomipramine Treatment of Obsessive-Compulsive Disorder497 cited
  • 1987Serotonergic Responsivity in Obsessive-Compulsive Disorder370 cited
  • 1983Obsessive-Compulsive Disorder347 cited
  • 2022Obsessive Compulsive Disorder306 cited
  • 1988Serotonergic Responsivity in Obsessive-Compulsive Disorder294 cited
  • 1992Serotonergic Function in Obsessive-Compulsive Disorder268 cited
  • 1988Serotonin Function in Obsessive-Compulsive Disorder242 cited
  • 1985The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam226 cited
  • 1990Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder220 cited
  • 1989Clomipramine in Obsessive-Compulsive Disorder151 cited
  • 1988Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings139 cited
  • 1991Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder120 cited
  • 1991Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder114 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

  • 2001Neurobiology and Clinical Pharmacology of Obsessive-Compulsive Disorder95 cited
  • 20025-HT2A promoter polymorphism −1438G/A in children and adolescents with obsessive-compulsive disorders95 cited
  • 2004Serotonergic Dissection of Obsessive Compulsive Symptoms: A Challenge Study with m-Chlorophenylpiperazine and Sumatriptan86 cited
  • 2011Current animal models of obsessive compulsive disorder: an update82 cited
  • 1999Single photon emission computed tomography op the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor74 cited
  • 1995m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation73 cited
  • 2001Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder71 cited
  • 2000Obsessive Compulsive Disorder: Serotonin and Beyond68 cited